126 related articles for article (PubMed ID: 1034920)
1. Central action of ergometrine.
Antkiewicz-Michaluk L
Pol J Pharmacol Pharm; 1976; 28(6):563-70. PubMed ID: 1034920
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of central stimulating effects between ephedrine and apomorphine].
Li Q; Li BH
Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):468-71. PubMed ID: 1819906
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic and serotonergic effects of ergometrine.
Antkiewicz-Michaluk L
Pol J Pharmacol Pharm; 1977; 29(3):273-9. PubMed ID: 887503
[TBL] [Abstract][Full Text] [Related]
4. Psychopharmacological profile of mesterolone.
Baran L; Przegaliński E
Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
[TBL] [Abstract][Full Text] [Related]
5. Central action of glaucine in rodents.
Jagiełło-Wójtowicz E; Kleinrok Z; Jusiak L; Matuszek B; Daniłoś J; Chodakowska A
Acta Pol Pharm; 1994; 51(2):179-84. PubMed ID: 7863789
[TBL] [Abstract][Full Text] [Related]
6. [Differences in the mechanisms of the stimulant and antidepressive effects of nomifensine].
Chermat R; Poncelet M; Simon P
J Pharmacol; 1985; 16(1):7-13. PubMed ID: 2860270
[TBL] [Abstract][Full Text] [Related]
7. The effect of bradykinin on central dopamine receptors.
Przesmycki K; Kleinrok Z
Pol J Pharmacol Pharm; 1976; 28(6):673-8. PubMed ID: 1034925
[TBL] [Abstract][Full Text] [Related]
8. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
[TBL] [Abstract][Full Text] [Related]
9. Central action of adrenaline.
Jagiełło-Wójtowicz E
Acta Physiol Pol; 1981; 32(2):169-80. PubMed ID: 7196677
[TBL] [Abstract][Full Text] [Related]
10. On some central effects of elymoclavine.
Roussinov K; Georgiev V; Petkov V; Lazarova M; Petkova B; Shopova S; Markovska V; Getova D; Draganova S
Acta Physiol Pharmacol Bulg; 1984; 10(4):28-35. PubMed ID: 6442955
[TBL] [Abstract][Full Text] [Related]
11. Further investigations on the effects of ergometrine and other ergot derivatives following injection into the nucleus accumbens of the rat.
Pijnenburg AJ; Honig WM; Boudier HA; Cools AR; Van der Heyden JA; Van Rossum JM
Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):103-15. PubMed ID: 984962
[TBL] [Abstract][Full Text] [Related]
12. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
Zharkovskiĭ AM; Matvienko OA; Nurk AM
Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
[TBL] [Abstract][Full Text] [Related]
13. The influence of antineoplaston A5 on the central dopaminergic structures.
Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z
Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193).
Wiczyńska B; Antkiewicz-Michaluk L; Pilc A; Chojnacka-Wójcik E; Przegaliński E
Pol J Pharmacol Pharm; 1989; 41(4):331-44. PubMed ID: 2636891
[TBL] [Abstract][Full Text] [Related]
15. The involvement of serotonin in the mechanism of central action of apomorphine.
Grabowska M
Pol J Pharmacol Pharm; 1976; 28(4):389-94. PubMed ID: 790347
[TBL] [Abstract][Full Text] [Related]
16. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
Bartoszyk GD; Harting J; Minck KO
J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
[TBL] [Abstract][Full Text] [Related]
17. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
[TBL] [Abstract][Full Text] [Related]
18. Central action of phenylethylamine in rats.
Jagiełło-Wójtowicz E
Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
Skuza G; Rogóz Z; Wieczorek A
Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of the dopaminergic system in the mode of action of the potential antidepressant trazium esilate.
Gyertyán I; Petöcz L; Bajnógel J; Szücs Z; Hegedüs M; Gyüre K; Gacsályi I; Krizsán D; Fekete MI
Arzneimittelforschung; 1989 Jul; 39(7):775-81. PubMed ID: 2551306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
